This project concerns the membrane proteins -- receptors and ion channels -- that underlie cellular excitability. In the next project period, VV will be exploited as a new system for the heterologous expression of these proteins in the membrane of mammalian and avian cells. 1. Vaccinia affords a new system for studying the 7-helix receptor-G protein interactions and the ion channel pathway, which employs direct coupling rather than soluble second messengers. Experiments will therefore work toward a complete reconstitution of this pathway. As a first step, the serotonin 5-HT-1A receptor will be expressed in primary cultures of cardiac atrial cells (chicks or guinea-pigs). It is expected that it will couple to the existing G protein(s), which in turn will activate K+ channels. Quantitative studies will follow. 2. It is of interest to understand the molecular basis for the diversity of voltage-dependent Ca++ channels from rat brain. Efforts will be continued to construct full-length clones for four classes of putative voltage-dependent Ca++ channels from rat brain. These clones will then be expressed in mammalian cell lines using VV and electrophysiological testing. Site-directed mutagenesis will follow. 3. Milligram quantities of channel proteins will be expressed and purified for structural studies.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM029836-10A1
Application #
3277530
Study Section
Neurological Sciences Subcommittee 1 (NLS)
Project Start
1981-04-01
Project End
1994-11-30
Budget Start
1990-12-01
Budget End
1991-11-30
Support Year
10
Fiscal Year
1991
Total Cost
Indirect Cost
Name
California Institute of Technology
Department
Type
Schools of Arts and Sciences
DUNS #
078731668
City
Pasadena
State
CA
Country
United States
Zip Code
91125
Lester, Henry A; Miwa, Julie M; Srinivasan, Rahul (2012) Psychiatric drugs bind to classical targets within early exocytotic pathways: therapeutic effects. Biol Psychiatry 72:907-15
Kovoor, Abraham; Seyffarth, Petra; Ebert, Jana et al. (2005) D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J Neurosci 25:2157-65
Rahman, Zia; Schwarz, Johannes; Gold, Stephen J et al. (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38:941-52
Petersson, E James; Brandt, Gabriel S; Zacharias, Niki M et al. (2003) Caging proteins through unnatural amino acid mutagenesis. Methods Enzymol 360:258-73
Rozengurt, Nora; Lopez, Ivan; Chiu, Chi-Sung et al. (2003) Time course of inner ear degeneration and deafness in mice lacking the Kir4.1 potassium channel subunit. Hear Res 177:71-80
Tong, Y; Brandt, G S; Li, M et al. (2001) Tyrosine decaging leads to substantial membrane trafficking during modulation of an inward rectifier potassium channel. J Gen Physiol 117:103-18
Li, M; Lester, H A (2001) Ion channel diseases of the central nervous system. CNS Drug Rev 7:214-40
Neusch, C; Rozengurt, N; Jacobs, R E et al. (2001) Kir4.1 potassium channel subunit is crucial for oligodendrocyte development and in vivo myelination. J Neurosci 21:5429-38
Maurer, J A; Elmore, D E; Lester, H A et al. (2000) Comparing and contrasting Escherichia coli and Mycobacterium tuberculosis mechanosensitive channels (MscL). New gain of function mutations in the loop region. J Biol Chem 275:22238-44
Kofuji, P; Ceelen, P; Zahs, K R et al. (2000) Genetic inactivation of an inwardly rectifying potassium channel (Kir4.1 subunit) in mice: phenotypic impact in retina. J Neurosci 20:5733-40

Showing the most recent 10 out of 64 publications